Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Carbohydrates > Glycosides > Aminoglycosides > Calicheamicins > Inotuzumab Ozogamicin
... > Organic Chemicals > Hydrocarbons > Hydrocarbons, Acyclic > Alkenes > Enediynes > Calicheamicins > Inotuzumab Ozogamicin
... > Organic Chemicals > Hydrocarbons > Hydrocarbons, Acyclic > Alkynes > Polyynes > Diynes > Enediynes > Calicheamicins > Inotuzumab Ozogamicin
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Immunoproteins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Inotuzumab Ozogamicin
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Inotuzumab Ozogamicin
... > Amino Acids, Peptides, and Proteins > Proteins > Globulins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Inotuzumab Ozogamicin

Preferred term

Inotuzumab Ozogamicin  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Besponsa
  • CMC544

Scope note

  • Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).

History note

  • 2020 (2004)

In other languages

URI

http://www.yso.fi/onto/mesh/D000080045

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/8/19, last modified 1/16/19